Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) and Cosmos Health (NASDAQ:COSM – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability.
Profitability
This table compares Greenland Mines Ltd. Common Stock and Cosmos Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Greenland Mines Ltd. Common Stock | N/A | -109.40% | -98.80% |
| Cosmos Health | -30.41% | -52.85% | -17.87% |
Valuation and Earnings
This table compares Greenland Mines Ltd. Common Stock and Cosmos Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Greenland Mines Ltd. Common Stock | N/A | N/A | -$10.55 million | ($0.32) | -0.72 |
| Cosmos Health | $65.27 million | 0.25 | -$19.15 million | ($0.64) | -0.41 |
Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Cosmos Health. Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 12.6% of Cosmos Health shares are owned by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are owned by insiders. Comparatively, 26.2% of Cosmos Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Greenland Mines Ltd. Common Stock has a beta of 7.05, meaning that its share price is 605% more volatile than the S&P 500. Comparatively, Cosmos Health has a beta of 4.83, meaning that its share price is 383% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and target prices for Greenland Mines Ltd. Common Stock and Cosmos Health, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Greenland Mines Ltd. Common Stock | 1 | 0 | 0 | 0 | 1.00 |
| Cosmos Health | 1 | 0 | 0 | 0 | 1.00 |
About Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
About Cosmos Health
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Receive News & Ratings for Greenland Mines Ltd. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenland Mines Ltd. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
